4.5 Article

Structure-Activity Relationships of Styrylquinoline and Styrylquinoxaline Derivatives as ?-Synuclein Imaging Probes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Chalcone Analogue as New Candidate for Selective Detection of α-Synuclein Pathology

Sho Kaide et al.

Summary: In this study, a series of chalcone analogues with different aryl groups were synthesized to evaluate their potential as alpha-syn imaging probes. The analogue with a 4-nitrophenyl group showed selective binding to alpha-syn aggregates, indicating promising utility as a clinically useful probe. Further structural optimization based on this analogue may lead to the development of a probe targeting alpha-syn aggregates in the future.

ACS CHEMICAL NEUROSCIENCE (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

[11C]MODAG-001-towards a PET tracer targeting α-synuclein aggregates

Laura Kuebler et al.

Summary: The newly developed MODAG-001 PET tracer based on anle138b showed high affinity in vitro and good penetration and stability in the mouse brain. However, no detectable binding to aggregated alpha SYN was found in human brain sections of LBD cases, possibly due to low abundance of aggregated alpha SYN against background protein.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Medicine, Research & Experimental

Synthesis and Evaluation of Fluorine-18 Labeled 2-Phenylquinoxaline Derivatives as Potential Tau Imaging Agents

Kaixiang Zhou et al.

Summary: This study evaluated three pairs of optically pure F-18-labeled 2-phenylquinoxaline derivatives as potential Tau imaging agents for AD diagnosis, showing high selectivity and affinity for Tau tangles over A beta. The PET probes (R)-[F-18]5 and (S)-[F-18]16 demonstrated promising brain penetration, kinetics, and stability, making them suitable candidates for Tau tangle imaging.

MOLECULAR PHARMACEUTICS (2021)

Review Chemistry, Medicinal

Alpha-Synuclein PET Tracer Development-An Overview about Current Efforts

Spela Korat et al.

Summary: The development of selective alpha-syn PET tracers faces challenges including low alpha-syn abundance, the need for high-affinity ligands, and the co-localization issue with other proteins. This review provides a comprehensive overview of current efforts in the development of selective alpha-syn PET tracers.

PHARMACEUTICALS (2021)

Article Biochemistry & Molecular Biology

Design, Synthesis, and Preliminary Evaluation of SPECT Probes for Imaging β-Amyloid in Alzheimer's Disease Affected Brain

Yuki Okumura et al.

ACS CHEMICAL NEUROSCIENCE (2018)

Article Chemistry, Medicinal

Design, synthesis, and in vitro evaluation of quinolinyl analogues for α-synuclein aggregation

Xuyi Yue et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)

Article Medicine, Research & Experimental

In Silico, in Vitro, and in Vivo Evaluation of New Candidates for α-Synuclein PET Imaging

Mathieu Verdurand et al.

MOLECULAR PHARMACEUTICS (2018)

Review Neurosciences

The Synucleinopathies: Twenty Years On

Michel Goedert et al.

JOURNAL OF PARKINSONS DISEASE (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Structure-Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer Disease

Tetsuro Tago et al.

JOURNAL OF NUCLEAR MEDICINE (2016)

Article Chemistry, Medicinal

Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor

Rares-Petru Moldovan et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Chemistry, Multidisciplinary

Copper-Catalyzed Hydroxylation of (Hetero)aryl Halides under Mild Conditions

Shanghua Xia et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)

Article Clinical Neurology

[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

Chun-Fang Xia et al.

ALZHEIMERS & DEMENTIA (2013)

Article Chemistry, Organic

High throughput one pot synthesis of 2-methylquinolines

Kiran Kumar H. Chandrashekarappa et al.

TETRAHEDRON LETTERS (2013)

Article Chemistry, Medicinal

Structure-Activity Relationships and in Vivo Evaluation of Quinoxaline Derivatives for PET Imaging of β-Amyloid Plaques

Masashi Yoshimura et al.

ACS MEDICINAL CHEMISTRY LETTERS (2013)

Article Neurosciences

α-synuclein Imaging: A Critical Need for Parkinson's Disease Research

Jamie L. Eberling et al.

JOURNAL OF PARKINSONS DISEASE (2013)

Article Clinical Neurology

Pathologic Accumulation of α-Synuclein and Aβ in Parkinson Disease Patients With Dementia

Paul T. Kotzbauer et al.

ARCHIVES OF NEUROLOGY (2012)

Article Chemistry, Multidisciplinary

Catalytic Hydrogenation with Frustrated Lewis Pairs: Selectivity Achieved by Size-Exclusion Design of Lewis Acids

Gabor Eros et al.

CHEMISTRY-A EUROPEAN JOURNAL (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

Pharmacokinetics of [18F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease

Anniina Snellman et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)

Article Chemistry, Medicinal

Novel quinoxaline derivatives for in vivo imaging of β-amyloid plaques in the brain

Mengchao Cui et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Article Clinical Neurology

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease

Michelle T. Fodero-Tavoletti et al.

Article Pharmacology & Pharmacy

In vitro characterisation of BF227 binding to α-synuclein/Lewy bodies

Michelle T. Fodero-Tavoletti et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2009)